Table 4.
Grade oral mucositis | Controls | Baxidil Onco® | ||||
---|---|---|---|---|---|---|
Total | Autologous | Allogeneic | Total | Autologous | Allogeneic | |
0 | 6 | 4 | 2 | 14 | 9 | 5 |
1 | 8 | 4 | 4 | 7 | 5 | 2 |
2 | 6 | 5 | 1 | 2 | 0 | 2 |
3 | b | 0 | 5 | 3 | 0 | 3 |
4 | 7 | 1 | 6 | 2 | 0 | 2 |
Grade oral mucositis | Controls | Baxidil Onco® | ||||
---|---|---|---|---|---|---|
Total | Autologous | Allogeneic | Total | Autologous | Allogeneic | |
0 | 6 | 4 | 2 | 14 | 9 | 5 |
1 | 8 | 4 | 4 | 7 | 5 | 2 |
2 | 6 | 5 | 1 | 2 | 0 | 2 |
3 | b | 0 | 5 | 3 | 0 | 3 |
4 | 7 | 1 | 6 | 2 | 0 | 2 |